Clinical and Echocardiographic Management of Patients With Heart Failure and Diabetes: SCODIAC Follow up Study
NCT04375943 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 406
Last updated 2020-05-06
Summary
The study has been carried out to determine diagnostic and therapeutic pathways in a group of HF diabetic patients and to verify whether the use of innovative antidiabetic therapies could modify echocardiographic parameters and influence cardiological therapy.
Conditions
Interventions
- DRUG
-
Antidiabetic
Verify whether the use of innovative antidiabetic therapies could modify echocardiographic parameters and influence cardiological therapy
Sponsors & Collaborators
-
Federico II University
lead OTHER
Principal Investigators
-
Ugo Oliviero · Federico II University
Eligibility
- Min Age
- 65 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-01
- Primary Completion
- 2019-04-01
- Completion
- 2019-09-01
Countries
- Italy
Study Locations
More Related Trials
-
Deformation Imaging by Strain in Chronic Heart Failure Over Gliflozins: an Echocardiographic Register on Sodium-GLucose coTransporter-2 Inhibitors
NCT05344963 ·Status: COMPLETED
-
Empagliflozin and Dapagliflozin in Patients Hospitalized for Acute Decompensated Heart Failure
NCT05776043 ·Status: RECRUITING ·Phase: PHASE3
-
Impact of DApagliflozin on Cardiac Function Following Anterior Myocardial Infarction in Non-Diabetic Patients
NCT05424315 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
ISGLT2 in Patients Without DM With Acute MI
NCT06903754 ·Status: COMPLETED
-
Dapagliflozin in the Treatment of Heart Failure
NCT05727423 ·Status: ACTIVE_NOT_RECRUITING
-
Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial
NCT04304560 ·Status: UNKNOWN ·Phase: PHASE2
-
SGLT2i and Incretin and CRTd.
NCT03282136 ·Status: COMPLETED ·Phase: PHASE4
-
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
NCT06435156 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.
NCT05934071 ·Status: UNKNOWN
-
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.
NCT04564742 ·Status: COMPLETED ·Phase: PHASE3
-
Improvement of Left Ventricular Ejection Fraction in ICD Patients Undergoing Therapy With Sacubitril/Valsartan
NCT03935087 ·Status: UNKNOWN
-
Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients
NCT02344641 ·Status: UNKNOWN ·Phase: NA
-
Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction
NCT02046044 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Trimetazidine in Diabetic Patients
NCT05556005 ·Status: UNKNOWN ·Phase: PHASE2
-
Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy
NCT05795400 ·Status: COMPLETED ·Phase: NA
-
Pilot Italian Cardiogenic Shock Initiative
NCT06475456 ·Status: RECRUITING
-
Short-term Effects of Dapagliflozin on Peak VO2 in HFrEF
NCT04197635 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction
NCT03087773 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Dapagliflozin on VT in Patients With Heart Failure.
NCT05550441 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
NCT00516074 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Dapagliflozin in Preventing Atrial Fibrillation Recurrence After Catheter Ablation
NCT06740786 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock
NCT03437369 ·Status: UNKNOWN ·Phase: PHASE4
-
REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs
NCT01803828 ·Status: COMPLETED ·Phase: PHASE4
-
Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction
NCT04475042 ·Status: UNKNOWN ·Phase: PHASE2
-
Observation of Italian Patients With Heart Failure Being Treated With Dapagliflozin in Clinical Practice
NCT05250011 ·Status: COMPLETED